Human/Mouse ADAM9 Ectodomain Antibody Summary
Ala206-Asp697
Accession # Q61072
*Small pack size (-SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of Human and Mouse ADAM9 by Western Blot. Western blot shows lysates of C2C12 mouse myoblast cell line and WI-38 human lung fibroblast cell line. PVDF membrane was probed with 1 µg/mL of Goat Anti-Human/Mouse ADAM9 Ectodomain Antigen Affinity-purified Polyclonal Antibody (Catalog # AF949) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (HAF017). Specific bands were detected for ADAM9 at approximately 110 and 80 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Western Blot Shows Human ADAM9 Specificity by Using Knockout Cell Line. Western blot shows lysates of HeLa human cervical epithelial carcinoma parental cell line and ADAM9 knockout HeLa cell line (KO). PVDF membrane was probed with 1 µg/mL of Goat Anti-Human/Mouse ADAM9 Ectodomain Antigen Affinity-purified Polyclonal Antibody (Catalog # AF949) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (HAF017). Specific bands were detected for ADAM9 at approximately 78 and 110 kDa (as indicated) in the parental HeLa cell line, but is not detectable in knockout HeLa cell line. GAPDH (AF5718) is shown as a loading control. This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Detection of Mouse ADAM9 by Western Blot Rescue of ADAM9 expression restores EMCV replication in ADAM9 KO cells. WT and ADAM9 KO HeLa cells were transduced with retroviral vectors with wild-type (WT) murine ADAM9 (mADAM9), catalytically inactive mutant ADAM9 (E>A), cytoplasmic-tail-deleted ( delta CT) ADAM9 constructs, or GFP control vectors. (A) WT, KO, and rescue cell lysates were analyzed by Western blot using two different ADAM9 antibodies. Top panel, rabbit anti-human ADAM9 that detects an epitope in the intracellular domain of human ADAM9 and cross-reacts with mouse ADAM9 (black asterisk). Middle panel, goat anti-mouse ADAM9 that detects the extracellular domain of murine ADAM9 but not human ADAM9 (blue asterisk). Bottom panel, anti-actin which detects both human and murine beta -actin. Top panel, WT but not KO cells expressed human ADAM9. Middle panel, rescue but not KO cells expressed murine ADAM9. Bottom panel, actin loading control. (B) WT clones, ADAM9 KO clones, and rescued ADAM9-expressing clones were infected with EMCV or CVB3 at various MOIs and incubated at 37°C for 24 h. Viability of EMCV-infected and CVB3-infected clones was measured by CellGlo ATP luminescence. (C) EMCV replication was quantified in infected culture supernatants by plaque assay. Neither the functional sequence of the ADAM9 metalloproteinase domain nor the cytoplasmic tail is required for EMCV infection. ***, P < 0.0001, KO versus WT and KO versus rescue. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/30723129), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of ADAM9 in Mouse Kidney. ADAM9 was detected in immersion fixed paraffin-embedded sections of mouse kidney using Goat Anti-Human/Mouse ADAM9 Ectodomain Antigen Affinity-purified Polyclonal Antibody (Catalog # AF949) at 10 µg/ml for 1 hour at room temperature followed by incubation with the Anti-Goat IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC004). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using VisUCyte Antigen Retrieval Reagent-Basic (Catalog # VCTS021). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to the membrane. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
Detection of ADAM9 in C2C12 cells by Flow Cytometry C2C12 cells were stained with Goat Anti-Human/Mouse ADAM9 Ectodomain Antigen Affinity-purified Polyclonal Antibody (Catalog # AF949, filled histogram) or isotype control antibody (Catalog # AB-108-C, open histogram) followed by Allophycocyanin-conjugated Anti-Goat IgG Secondary Antibody (Catalog # F0108). View our protocol for Staining Membrane-associated Proteins.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: ADAM9
ADAM9, also known as MDC9 or meltrin gamma, is a member of the ADAM family that contains a disintegrin and metalloprotease-like domain (1). Like other membrane‑anchored ADAMs, ADAM9 consists of a pro domain with a cysteine switch and furin cleavage sequence, a catalytic domain with the zinc-binding site and Met-turn expected for reprolysins, a disintegrin-like domain, a cysteine-rich domain, an EGF-like domain, a transmembrane domain, and the cytoplasmic domain. ADAM9 is able to cleave peptides corresponding to cleavage sites of tumor necrosis factor-alpha (TNF-alpha ), the p75-TNF receptor, the beta -amyloid protein precursor, and the c-kit ligand-1, implying that it may participate in shedding of these membrane proteins (2). In fact, ADAM9 has been shown to shed membrane‑anchored heparin‑binding EGF-like growth factor (3). In addition, it also cleaves oxidized insulin B-chain and fibronectin (2, 4). Besides its catalytic activity, ADAM9 functions as an adhesion molelcule through binding of its disintegrin domain to integrins such as alpha v beta 5 and alpha 6 beta 1 (5, 6). The cytoplasmic domain of ADAM9 interacts with Src homology 3
(SH3)‑containing proteins and protein kinase C, and may mediate different signaling pathways (3, 7). ADAM9 is widely expressed in tissues (8).
- Moss, M.L. et al. (2001) Drug Discov. Today 6:417.
- Roghani, M. et al. (1999) J. Biol. Chem. 274:3531.
- Izumi, Y. et al. (1998) EMBO J. 17:7260.
- Schwettmann, L. and H. Tschesche (2001) Protein. Expr. Purif. 21:65.
- Nath, D. et al. (2000) J. Cell Sci. 113:2319.
- Zhou, M. et al. (2001) Biochem. Biophys. Res. Comm. 280:574.
- Howard, L. et al. (1999) J. Biol. Chem. 274:31693.
- Weskamp, G. et al. (1996) J. Cell Biol. 132:717.
Product Datasheets
Citations for Human/Mouse ADAM9 Ectodomain Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
15
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
An Antibody of the Secreted Isoform of Disintegrin and Metalloprotease 9 (sADAM9) Inhibits Epithelial-Mesenchymal Transition and Migration of Prostate Cancer Cell Lines
Authors: Jotatsu, Y;Sung, SY;Wu, MH;Takeda, S;Hirata, Y;Maeda, K;Fang, SB;Chen, KC;Shigemura, K;
International journal of molecular sciences
Species: Human, Mouse
Sample Types: Whole Cells
Applications: Neutralization -
ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection
Authors: Bazzone, LE;Zhu, J;King, M;Liu, G;Guo, Z;MacKay, CR;Kyawe, PP;Qaisar, N;Rojas-Quintero, J;Owen, CA;Brass, AL;McDougall, W;Baer, CE;Cashman, T;Trivedi, CM;Gack, MU;Finberg, RW;Kurt-Jones, EA;
Nature communications
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma
Authors: WC Cheng, CY Chang, CC Lo, CY Hsieh, TT Kuo, GC Tseng, SC Wong, SF Chiang, KC Huang, LC Lai, TP Lu, KSC Chao, YP Sher
Theranostics, 2021-01-26;11(8):3661-3675.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Loss of ADAM9 Leads to Modifications of the Extracellular Matrix Modulating Tumor Growth
Authors: Anna N. Abety, Elke Pach, Nives Giebeler, Julia E. Fromme, Lavakumar Reddy Aramadhaka, Cornelia Mauch et al.
Biomolecules
-
A Disintegrin and Metalloproteinase 9 Domain (ADAM9) Is a Major Susceptibility Factor in the Early Stages of Encephalomyocarditis Virus Infection
Authors: LE Bazzone, M King, CR MacKay, PP Kyawe, P Meraner, D Lindstrom, J Rojas-Quin, CA Owen, JP Wang, AL Brass, EA Kurt-Jones, RW Finberg
MBio, 2019-02-05;10(1):.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Sorting nexin 9 (SNX9) regulates levels of the transmembrane disintegrin and metalloproteinase (ADAM)-9 at the cell surface
Authors: KJ Mygind, T Störiko, ML Freiberg, J Samsøe-Pet, J Schwarz, OM Andersen, M Kveiborg
J. Biol. Chem., 2018-04-05;0(0):.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
Authors: CY Lin, CF Cho, ST Bai, JP Liu, TT Kuo, LJ Wang, YS Lin, CC Lin, LC Lai, TP Lu, CY Hsieh, CN Chu, DC Cheng, YP Sher
Sci Rep, 2017-11-08;7(1):15108.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis
Authors: N Giebeler, A Schönefu beta, J Landsberg, T Tüting, C Mauch, P Zigrino
Oncogene, 2017-05-29;0(0):.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC -
Loss of ADAM9 expression impairs beta 1 integrin endocytosis, focal adhesion formation and cancer cell migration
Authors: Kasper J. Mygind, Jeanette Schwarz, Pranshu Sahgal, Johanna Ivaska, Marie Kveiborg
Journal of Cell Science
-
The association between laminin and microglial morphology in vitro
Authors: Wing Yip Tam
Sci Rep, 2016-06-23;6(0):28580.
Species: Mouse
Sample Types: Whole Cells
Applications: IHC -
The sorting protein PACS-2 promotes ErbB signalling by regulating recycling of the metalloproteinase ADAM17
Authors: Sarah Louise Dombernowsky, Jacob Samsøe-Petersen, Camilla Hansson Petersen, Rachael Instrell, Anne-Mette Bornhardt Hedegaard, Laurel Thomas et al.
Nature Communications
-
High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer
Authors: JUN ZHANG, JUAN QI, NING CHEN, WEINENG FU, BAOSEN ZHOU, ANGUANG HE
Oncology Letters
-
The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein.
Authors: Delarasse C, Auger R, Gonnord P, Fontaine B, Kanellopoulos JM
J. Biol. Chem., 2010-11-16;286(4):2596-606.
Species: Mouse
Sample Types: Cell Lysates, Whole Cells
Applications: ICC, Western Blot -
Accelerated wound repair in ADAM-9 knockout animals.
Authors: Mauch C, Zamek J, Abety AN, Grimberg G
J. Invest. Dermatol., 2010-04-08;130(8):2120-30.
Species: Mouse
Sample Types: Cell Lysates
Applications: Western Blot -
Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3.
Authors: Saunders WB, Bohnsack BL, Faske JB, Anthis NJ, Bayless KJ, Hirschi KK, Davis GE
J. Cell Biol., 2006-10-09;175(1):179-91.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human/Mouse ADAM9 Ectodomain Antibody
There are currently no reviews for this product. Be the first to review Human/Mouse ADAM9 Ectodomain Antibody and earn rewards!
Have you used Human/Mouse ADAM9 Ectodomain Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image